Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Whoopi Goldberg made it clear she had no involvement with the promotion of any kind of products and warned fans against ...

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

The EGOT winner railed against an ad that's circulating on social media with a manipulated version of her promoting "bad ...

We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...

"The View" co-host Whoopi Goldberg addressed a "phony weight loss ad" circulating on Instagram during the show on Wednesday ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

The coach told his players that its 30-point loss at Florida would ultimately be good for the No. 1 Vols. "Now, we are going to learn what we’ve got to do to get better," Barnes said.